An observational study on QT interval changes with Hydroxychloroquine used as prophylaxis in COVID exposure risk individuals
Not Applicable
Not yet recruiting
- Registration Number
- CTRI/2020/05/025289
- Lead Sponsor
- P Vamsavardhana Reddy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All High COVID exposure risk individuals aged above 18 years & weight > 35 kg consuming Hydroxychloroquine as prophylaxis for COVID-19
Exclusion Criteria
Individuals not willing to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Magnitude and frequency of QTc changes. <br/ ><br>Timepoint: At 8 weeks
- Secondary Outcome Measures
Name Time Method 1)Time interval to develop QTc prolongation after HCQ intake. <br/ ><br>2)Other short term adverse drug reactions (ADRs) â?? serious/ Nonserious. <br/ ><br> <br/ ><br>Timepoint: At 8 weeks